Jingfeng Pharmaceutical (000908) Commentary Report: New batch of methylprednisolone tablets and bivalirudin for injection are further enriched in the United States

Jingfeng Pharmaceutical (000908) Commentary Report: New batch of methylprednisolone tablets and bivalirudin for injection are further enriched in the United States Event: The company issued an announcement on June 28, 2019. The company’s holding subsidiary Sungen Pharma, LLC (hereinafter referred


Diou Home (002798): High-growth engineering retail

Diou Home (002798): High-growth engineering retail Investment Highlights Event: The company released its 2019 Interim Report. From January to June 2019, the company achieved operating income of 249,848. 660,000 yuan, +30 a year. 13%; net profit attributable to shareholders of